SYNERGISTIC PHARMACEUTICAL COMBINATION COMPRISING AN ESTROGEN RECEPTOR ANTAGONIST AND A PROGESTIN
OA: closed
Abstract
The present invention relates to the coadministration of an estrogen receptor antagonist and a progestin to treat gynecological diseases resulting from abnormal growth of uterine tissue, such as endometriosis or uterine fibroids.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-09T06:07:56.200469+00:00